The All India Institute of Medical Sciences (AIIMS) in New Delhi has introduced a free, advanced blood test aimed at revolutionizing epilepsy treatment. This initiative is designed to help doctors tailor medication dosages more accurately for epilepsy patients, thereby enhancing therapeutic outcomes and minimizing adverse effects.
How the Test Works
The blood test measures the concentration of anti-epileptic drugs in a patient’s system. By determining the exact levels of medication, physicians can adjust doses to ensure they are within the therapeutic range—effective yet not toxic. This personalized approach is especially beneficial for patients who do not respond well to standard dosages or experience severe side effects.
Benefits for Patients
- Improved Seizure Control: Accurate dosing helps reduce the frequency and severity of seizures.
- Reduced Side Effects: Avoiding overmedication minimizes drowsiness, dizziness, and other adverse reactions.
- Cost Savings: The test is offered free of charge, removing financial barriers for patients.
Expert Opinions
Dr. Rakesh Kumar, a neurologist at AIIMS, stated, “This test allows us to move from a trial-and-error approach to a more scientific method of prescribing epilepsy medications. It is a significant step forward in personalized medicine.”
Implementation and Availability
The service is currently available at AIIMS Delhi’s neurology department. Patients with epilepsy who are on medication can request the test during their consultation. The hospital plans to expand the program to other centers if the pilot proves successful.
Epilepsy affects millions in India, and many patients struggle with treatment due to lack of access to therapeutic drug monitoring. This initiative aims to bridge that gap and improve quality of life for those living with the condition.
